The invention relates to compounds of structural formula (I):(see formula I)or a pharmaceutically acceptable salt, solvate, clathrate, and prodrugthereof, whereinR a, R b, and R2 are defined herein. These compounds inhibit tubulinpolymerizationand/or target vasculature and are useful for treating proliferative disorders,such ascancer.